Multimodal Imaging Market Size, Share, Industry, Forecast and outlook (2026-2033)

Multimodal Imaging Market Size

The Global Multimodal Imaging Market was valued at approximately US$ 4.81 billion in 2025 and is projected to reach US$ 7.56 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2026-2033.

Multimodal imaging refers to combining two or more imaging modalities to produce an improvised image for comprehansive analysis. Usually the imaging in clinical practice or research setting is done using a single modality such as MRI, CT, X-Ray, PET, SPECTS etc, which can only provide limited details regarding the subject. With multimodal imaging, multidimensional data of the subject relating its macroscopic and microscopic structure, dynamics, function, and chemical composition can be generated. 

Also known as Multimodal Medical Image Fusion (MMIF), multimodal imaging combines imaging modalities such as CT/PET, MRI/PET-SPECT, MRI-CT etc. Currently multimodal imaging has been revolutionizing drug discovery by assissting in preclincal and clinical diagnostics. Several market leaders have developed multimodal imaging instrument modalities which are currently being used for diagnosing chronic condition such as cancer, cardiovascular diseases etc. 

Multimodal Imaging Market : Key Takeaways

•  US$ 7.56 billion  is the 2033 market opportunity. The multimodal imaging market reached US$ 4.81 billion in 2025 and is projected to expand at a 5.8% CAGR through 2026-2033, driven by demand for more comprehensive diagnostic insights.
• North America remains the center of gravity. With a 46.70% market share, the region leads due to advanced healthcare infrastructure, high healthcare spending, strong diagnostic capabilities and significant investments in medical imaging research.
• Asia-Pacific is the growth engine. The region is identified as the fastest-growing market, supported by rising healthcare infrastructure investments, increasing chronic disease burden and growing adoption of advanced diagnostic technologies.
• Software is becoming the core value layer. Software accounted for approximately 65.22% of the market, reflecting its importance in image fusion, data integration, image contouring, automation and analysis across multiple imaging modalities.
• Multimodal imaging is shifting diagnosis from single-modality views to integrated insights. Combining CT/PET, MRI/PET-SPECT and MRI-CT enables multidimensional analysis that can support more accurate diagnosis, research, treatment planning and personalized medicine.
• AI is becoming a diagnostic accelerator. Integration of artificial intelligence with multimodal imaging is strengthening automated image interpretation and clinical decision-making, particularly across oncology, neurology, ophthalmology and cardiovascular applications.
• Oncology is a major innovation frontier. Multimodal imaging is increasingly being used alongside radiomics, molecular data, digital pathology and clinical information to improve cancer research, clinical trials and treatment decisions.
• Existing imaging infrastructure creates a software-led opportunity. Multimodal imaging software can process images generated by existing CT, MRI, X-ray and other systems, reducing the need for entirely new hardware and creating recurring software/subscription opportunities.
• High equipment and maintenance costs remain a barrier. Complex multimodal imaging systems require substantial upfront investment and ongoing maintenance, while shortages of professionals capable of interpreting complex multimodal datasets can constrain adoption.
• Vendor-neutral interoperability is gaining importance. Software capable of integrating images from different imaging modalities and equipment vendors can improve workflow flexibility and expand multimodal imaging adoption across hospitals and diagnostic centers.

Multimodal Imaging Market Summary

For more details on this report - Request for Sample

Multimodal Imaging Market Dynamics

Rising applications of multimodal imaging

In the current scenario, the imaging diagnostics market is majorly dominated by modalities such as MRI scan, CT scan, X-Ray, PET, SPECT etc. These imaging modalities provide comprehansive images of the subject with emphasis on a specific parameter. These imaging modalities are used in clinical setting to diagnose cancer, neurological conditons, degenerative conditions, musculoskeletal conditons, fractures etc. None of these imaging modalities provide information in multiple angles or multiple parameters. 

With the advent of technology multimodal imaging has come into limelight wich combines images generated from two or more imaging modalities and provide multidimensional data that can be utilized for accurate diagnostics, research and development, personalizing the therapy etc. In recent times, multimodal imaging has aquired center of attention when it comes to imaging diagnostics.

Many preclinical and clinical studies were being conducted to evaluate the efficacy of multimodal imaging in diagnositics and therapeutics. Integrating multimodal imaging with artificial intelligence to generate conclusion is one of a practice that is expected to boost the market growth. Moreover, the application of multimodal imaging is rising in various conditions related to onclology, neurology, ophthalmology, cardiovadscular system which is expected to majorly boost the market growth.

Moreover rising prevalance of chronic diseases, rising investments in healthcare infrastructure, rising emphasis on personalized medicine are expected to drive the market growth.

Restraints

Factors such as high cost which includes the initial investment on the complex equipment and the ongoing maintance costs is expected to restrain the market. Moreover, lack of professionals who are skilled enough to do the complex analysis of the results put forth by the software is another factor which is expected to  to restrain the market growth.

Multimodal Imaging Market Segment Analysis

The global multimodal imaging market is segmented based on product type, application, end user and region.

The software in the product type segment accounted for approximately 65.22% of the global multimodal imaging market share

Multimodal imaging is based on culminating the images generated by various imaging modalities such as MRI, CT, X-ray etc. The major goal of multimodal imaging is to analyse these images and provide a diagnostic or therapeutic conclusion. This analysis can done by using several softwares which process the input data. 

This input data doesn’t necessarily have to be derived from a multimodal instrument like MRI-CT, PET-CT, MRI-SPECT etc, but can be derived from a single instrument with only one function. i.e., either CT scans, MRI images, radiographic images etc. For multimodal imaging analysis the software plays a crucial rule as it should contain specific features such as streamling the data, image fusion, image countouring,  automation etc. Moreover, these softwares work irrespective of the imaging modality, implying their versitality. 

The necissity of new multimodal imaging device is less, as the input images from the software can be derived from already existing devices. In addition, considering the replacement ratio, the softwares used for multimodal imaging anlaysis come with subscription basis which needs to be renewed from time to time making it indispensible. Whereas only one time investment is made in multimodal imaging devices and its replacement ratio is very low as they have higher lifetime. 

For instance, the mutimodal workspace software offered by Koninklijke Philips N.V. is compatible to philips imaging devices and non-philips imaging devices providing vendor neutral support for multimodality image fusion. 

Siemens Healthineers AG another major company in the market has been offering multimodal imaging software syngo.via that can be streamlined with imaging devices in hospital settings for oncology, cardiovascular care, neurology, and neuclear medicine. The software can analyse images generated from CT scanner, MRI, PET//CT, SPECT/CT and mammography.

Multimodal Imaging Market Geographical Share

North America is expected to dominate the market with 46.70% share in the global multimodal imaging Market

North America is expected to dominate the market due to its advanced healthcare infrastructure and well equipped state of the art diagnostic centers and hospital settings. Majority of the companies that have revolutionized the medical diagnositc imaging industry have originated from North America and have established a stronghold market position in the region. Moreover, North America expenditure in healthcare is far higher than any other high-income countries.

In addition, major countries in North America such as U.S. and Canada have become hub for companies that are driving innovation in the medical imaging. Since, multimodal imaging is currently revolutionizing preclinical and clinical studies, North America spends higher than any other region for research activities. In addition, strategic alliances by academia, industry and healthcare settings are higher in U.S. which is another parameter contributing to major market share for North America.

For instance, on November 27, 2023, Cleveland Clinic a major hospital in the U.S. has collaborated with Canon Inc., to bring innovative imaging and healthcare IT technologies with the aim to improve diagnosis, and care for patients. This collaboration focuses on cardiology, neurology and musculoskeletal conditions in three main aspects such as pre-clinical imaging, clinical imaging and image analysis.

In September 2022, a report published by United States Government Accountability Office in collaboration with National Academy of Medicine has stated that U.S. is well equipped with technology such as deep learning, machine learning in the healthcare setting, which is making the diagnosis easier and faster. These technologies were found to be mostly integrated with X-ray and MRI imaging modalities. 

Multimodal Imaging Companies

The major players in the multimodal imaging market include GE HealthCare., Koninklijke Philips N.V., Siemens Healthineers AG, ZEISS Group, CANON MEDICAL SYSTEMS CORPORATION, Mediso Ltd., NIDEK CO., LTD. and SOPHiA GENETICS. among others. 

Multimodal Imaging Market Recent Developments

• July 2026 – Multimodal AI advances precision oncology imaging
  Researchers highlighted multimodal AI approaches that integrate MRI and PET/CT imaging with histopathology and liquid biopsy data for bone-tumor diagnosis. The approach supports more comprehensive clinical decision-making by combining anatomical, functional and molecular information across diagnostic modalities.
• July 2026 – Deep learning strengthens multimodal medical image fusion
  A 2026 review highlighted rapid advances in deep-learning methods for multimodal medical image fusion, particularly for combining complementary information from MRI, CT, PET and SPECT. These developments are supporting higher-quality fused images and AI-assisted diagnostic workflows.
• April 2026 – AI enables synthetic PET generation from MRI
  Researchers evaluated generative AI approaches for producing synthetic PET images from MRI data, addressing the limited availability and higher cost of PET imaging. The development could expand multimodal MRI-PET analysis while reducing dependence on separate functional imaging procedures.
• February 2026 – AI accelerates multimodal biomedical imaging research
  A major review of AI advances in multimodal biomedical imaging highlighted the growing use of foundation models and transformer-based architectures to integrate information from multiple imaging modalities. These technologies are being explored to improve image analysis, fusion and clinical interpretation.
• February 2026 – NVIDIA expands AI-powered medical imaging capabilities
  NVIDIA highlighted growing adoption of AI in medical imaging, including image analysis, segmentation and radiology workflows. Its healthcare AI ecosystem supports the integration of medical imaging data with multimodal and conversational AI, strengthening automated interpretation and clinical decision-support capabilities.
• February 2026 – Foundation models reshape multimodal medical imaging
  Research into medical imaging foundation models showed a shift from task-specific AI systems toward general-purpose models that can adapt across imaging modalities, anatomical regions and clinical applications. This trend is expected to accelerate the development of scalable multimodal imaging solutions.
• January 2026 – Multimodal vision foundation model targets musculoskeletal imaging
  Researchers introduced a multimodal vision foundation model trained using large-scale knee X-ray and MRI datasets. The model demonstrated strong performance across multiple diagnostic tasks and cross-anatomy generalization, highlighting the potential of foundation models for integrated multimodal imaging analysis.
• 2026 – AI-driven image fusion improves PET-MRI, CT-MRI and SPECT-MRI analysis
  Emerging deep-learning image-fusion architectures are improving the integration of structural and functional information across PET-MRI, CT-MRI and SPECT-MRI datasets. These advances are aimed at producing sharper, information-rich images while improving cross-modality generalization.

Why Purchase the Report?

• To visualize the global multimodal imaging market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of multimodal imaging market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global multimodal imaging market report would provide approximately 56 tables, 51 figures, and 187 Pages.

Target Audience 

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies